Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care CoSHSE:688410 +0.38%88 EV-to-FCF is 30.45 as of Aug. 01, 2026, which is 25% above its 10-year median of 24.42. GuruFocus rates SHSE:688410 with a GF Score™ of 88/100 and a GF Value™ of ¥15.44 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 416 Medical Devices & Instruments companies, SWS Hemodialysis Care Co ranks worse than 59.86% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SWS Hemodialysis Care Co's Enterprise Value is ¥3,288.5 Mil.
SWS Hemodialysis Care Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥108.0 Mil. Therefore, SWS Hemodialysis Care Co's EV-to-FCF for today is 30.45.
The historical rank and industry rank for SWS Hemodialysis Care Co's EV-to-FCF or its related term are showing as below:
SHSE:688410'
s EV-to-FCF Range Over the Past 10 Years
Min: -108.48 Med: 24.42 Max: 93.89
Current: 30.45
During the past 12 years, the highest EV-to-FCF of SWS Hemodialysis Care Co was 93.89. The lowest was -108.48. And the median was 24.42.
SHSE:688410's EV-to-FCF is ranked worse than 59.86% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.71
vs SHSE:688410: 30.45
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SWS Hemodialysis Care Co (SHSE:688410) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SWS Hemodialysis Care Co's PE Ratio (TTM) for today is calculated as:
SWS Hemodialysis Care Co's share price for today is ¥10.59.
SWS Hemodialysis Care Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.367.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SWS Hemodialysis Care Co EV-to-FCF Related Terms
SWS Hemodialysis Care Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688410 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's EV-to-FCF falls into.
SWS Hemodialysis Care Co's current Enterprise Value is ¥3,288.5 Mil.
SWS Hemodialysis Care Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥108.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co (SHSE:688410) has a EV-to-FCF of 30.45 as of Aug. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SWS Hemodialysis Care Co and its competitors. This is 25% above median its historical median of 24.42. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #249 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 59.9%.
Is SWS Hemodialysis Care Co's EV-to-FCF too high?
SWS Hemodialysis Care Co's current EV-to-FCF of 30.45 is 25% above median its 10-year median of 24.42. The Medical Devices & Instruments industry median EV-to-FCF is 23.71. SWS Hemodialysis Care Co's value of 30.45 is 28.4% above this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #249 out of 416 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SWS Hemodialysis Care Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #249 out of 416 companies for EV-to-FCF. This places SWS Hemodialysis Care Co in the lower half of its industry. The industry median EV-to-FCF is 23.71. SWS Hemodialysis Care Co's value of 30.45 is 28.4% above this benchmark. While the company's 10-year median is 24.42 vs. the industry median of 23.71, SWS Hemodialysis Care Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.71, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current EV-to-FCF of 30.45 is 28.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current EV-to-FCF is 30.45, which is 25% above median its own 10-year median of 24.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.44, compared to a current price of ¥10.59 — trading 31.4% below its estimated fair value. The current EV-to-FCF is 30.45, which is 25% above median its 10-year median of 24.42 and 28.4% above the Medical Devices & Instruments industry median of 23.71. SWS Hemodialysis Care Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current EV-to-FCF is 30.45 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥10.59 is trading 31.4% below its estimated GF Value™ of ¥15.44.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
EV-to-FCF: 30.45 (25% above median its 10-year median of 24.42)
GF Value™: ¥15.44 vs. price of ¥10.59 (31.4% below fair value)
Industry Position: 28.4% above the Medical Devices & Instruments median (#249 of 416)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
88GF Score
Get the complete analysis for SHSE:688410
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
